Pluripotent Stem Cell Differentiation

Oral

F-3004 - DEVELOPMENT OF COMMERCIALLY VIABLE cGMP MANUFACTURING PROCESSES FOR THE PRODUCTION OF HUMAN INDUCED PLURIPOTENT STEM CELLS DERIVATIVES FOR CLINICAL APPLICATIONS

6/22/2018
19:00 - 20:00

Krishna M. Panchalingam

Lonza Walkersville Inc., Maryland, United States

Presentation(s):

    Send Email for Krishna Panchalingam


    Assets

    F-3004 - DEVELOPMENT OF COMMERCIALLY VIABLE cGMP MANUFACTURING PROCESSES FOR THE PRODUCTION OF HUMAN INDUCED PLURIPOTENT STEM CELLS DERIVATIVES FOR CLINICAL APPLICATIONS



    Attendees who have favorited this

    Please enter your access key

    The asset you are trying to access is locked. Please enter your access key to unlock.

    Send Email for F-3004 - DEVELOPMENT OF COMMERCIALLY VIABLE cGMP MANUFACTURING PROCESSES FOR THE PRODUCTION OF HUMAN INDUCED PLURIPOTENT STEM CELLS DERIVATIVES FOR CLINICAL APPLICATIONS